| Differentiation and gene expression profile of tumor-associated macrophages A Schmieder, J Michel, K Schönhaar, S Goerdt, K Schledzewski Seminars in cancer biology 22 (4), 289-297, 2012 | 264 | 2012 |
| Macrophage activation in human diseases JL Schultze, A Schmieder, S Goerdt Seminars in Immunology 27 (4), 249-256, 2015 | 137 | 2015 |
| Liver sinusoidal endothelium: a microenvironment‐dependent differentiation program in rat including the novel junctional protein liver endothelial differentiation‐associated … C Géraud, K Schledzewski, A Demory, D Klein, M Kaus, F Peyre, C Sticht, ... Hepatology 52 (1), 313-326, 2010 | 117 | 2010 |
| Patient preferences for psoriasis treatments: process characteristics can outweigh outcome attributes ML Schaarschmidt, A Schmieder, N Umar, D Terris, M Goebeler, S Goerdt, ... Archives of dermatology 147 (11), 1285-1294, 2011 | 100 | 2011 |
| cFLIP regulates skin homeostasis and protects against TNF-induced keratinocyte apoptosis D Panayotova-Dimitrova, M Feoktistova, M Ploesser, B Kellert, M Hupe, ... Cell reports 5 (2), 397-408, 2013 | 95 | 2013 |
| Outcomes associated with matching patients' treatment preferences to physicians' recommendations: study methodology N Umar, D Litaker, ML Schaarschmidt, WK Peitsch, A Schmieder, ... BMC health services research 12, 1-10, 2012 | 79 | 2012 |
| Unique cell type-specific junctional complexes in vascular endothelium of human and rat liver sinusoids C Geraud, K Evdokimov, BK Straub, WK Peitsch, A Demory, Y Dörflinger, ... PloS one 7 (4), e34206, 2012 | 75 | 2012 |
| Patient preferences for psoriasis treatments: impact of treatment experience ML Schaarschmidt, N Umar, A Schmieder, DD Terris, M Goebeler, ... Journal of the European Academy of Dermatology and Venereology 27 (2), 187-198, 2013 | 72 | 2013 |
| Treatment satisfaction of patients with psoriasis. ML Schaarschmidt, C Kromer, R Herr, A Schmieder, S Goerdt, WK Peitsch Acta dermato-venereologica 95 (5), 2015 | 71 | 2015 |
| Comorbidities significantly impact patients’ preferences for psoriasis treatments A Schmieder, ML Schaarschmidt, N Umar, DD Terris, M Goebeler, ... Journal of the American Academy of Dermatology 67 (3), 363-372, 2012 | 70 | 2012 |
| Lip cancer: retrospective analysis of 181 cases C Géraud, W Koenen, L Neumayr, G Doobe, A Schmieder, C Weiss, ... JDDG: Journal der Deutschen Dermatologischen Gesellschaft 10 (2), 121-127, 2012 | 70 | 2012 |
| Endothelial transdifferentiation in hepatocellular carcinoma: loss of Stabilin‐2 expression in peri‐tumourous liver correlates with increased survival C Géraud, C Mogler, A Runge, K Evdokimov, S Lu, K Schledzewski, ... Liver International 33 (9), 1428-1440, 2013 | 64 | 2013 |
| Patient preferences for treatment of psoriasis with biologicals: a discrete choice experiment C Kromer, ML Schaarschmidt, A Schmieder, R Herr, S Goerdt, WK Peitsch PLoS One 10 (6), e0129120, 2015 | 62 | 2015 |
| Prognostic value of immune cell infiltration, tertiary lymphoid structures and PD-L1 expression in Merkel cell carcinomas DS Behr, WK Peitsch, C Hametner, F Lasitschka, R Houben, K Schönhaar, ... International journal of clinical and experimental pathology 7 (11), 7610, 2014 | 58 | 2014 |
| Matching physicians’ treatment recommendations to patients’ treatment preferences is associated with improvement in treatment satisfaction N Umar, M Schaarschmidt, A Schmieder, WK Peitsch, I Schöllgen, ... Journal of the European Academy of Dermatology and Venereology 27 (6), 763-770, 2013 | 56 | 2013 |
| Isogentisin—a novel compound for the prevention of smoking-caused endothelial injury A Schmieder, S Schwaiger, A Csordas, A Backovic, B Messner, G Wick, ... Atherosclerosis 194 (2), 317-325, 2007 | 46 | 2007 |
| Synergistic activation by p38MAPK and glucocorticoid signaling mediates induction of M2‐like tumor‐associated macrophages expressing the novel CD20 homolog MS4A8A A Schmieder, K Schledzewski, J Michel, JP Tuckermann, L Tome, C Sticht, ... International journal of cancer 129 (1), 122-132, 2011 | 43 | 2011 |
| The methylisothiazolinone epidemic goes along with changing patients' characteristics–After cosmetics, industrial applications are the focus A Schnuch, S Schubert, H Lessmann, J Geier, IVDK, U Beiteke, ... Contact Dermatitis 82 (2), 87-93, 2020 | 37 | 2020 |
| The shedded ectodomain of Lyve-1 expressed on M2-like tumor-associated macrophages inhibits melanoma cell proliferation C Dollt, K Becker, J Michel, S Melchers, CA Weis, K Schledzewski, ... Oncotarget 8 (61), 103682, 2017 | 37 | 2017 |
| Patient Preferences for Treatment of Basal Cell Carcinoma: Importance of Cure and Cosmetic Outcome. I Martin, ML Schaarschmidt, A Glocker, R Herr, A Schmieder, S Goerdt, ... Acta dermato-venereologica 96 (3), 2016 | 30 | 2016 |
